|
Report No. : |
337421 |
|
Report Date : |
21.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
ANZCHEM PTY LTD |
|
|
|
|
Registered Office : |
'Building A' Level
1, 11 Talavera Road North Ryde Nsw, 2113 |
|
|
|
|
Country : |
Australia |
|
|
|
|
Financials (as on) : |
31.08.2014 |
|
|
|
|
Date of Incorporation : |
30.12.2002 |
|
|
|
|
Legal Form : |
Private company |
|
|
|
|
Line of Business : |
Subject operates as a supplier of pharmaceuticals, veterinarian and
food ingredient products. |
|
|
|
|
No. of Employee : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Australia |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
AUSTRALIA ECONOMIC OVERVIEW
Following two decades of continuous growth, low unemployment, contained inflation, very low public debt, and a strong and stable financial system, Australia enters 2015 facing a range of growth constraints, principally driven by a sharp fall in global prices of key export commodities. Although demand for resources and energy from Asia and especially China has grown rapidly, creating a channel for resources investments and growth in commodity exports, sharp drops in current prices have already impacted growth. The services sector is the largest part of the Australian economy, accounting for about 70% of GDP and 75% of jobs. Australia was comparatively unaffected by the global financial crisis as the banking system has remained strong and inflation is under control. Australia has benefited from a dramatic surge in its terms of trade in recent years, although this trend could reverse or slow due to falling global commodity prices. Australia is a significant exporter of natural resources, energy, and food. Australia's abundant and diverse natural resources attract high levels of foreign investment and include extensive reserves of coal, iron, copper, gold, natural gas, uranium, and renewable energy sources. A series of major investments, such as the US$40 billion Gorgon Liquid Natural Gas project, will significantly expand the resources sector. Australia is an open market with minimal restrictions on imports of goods and services. The process of opening up has increased productivity, stimulated growth, and made the economy more flexible and dynamic. Australia plays an active role in the World Trade Organization, APEC, the G20, and other trade forums. Australia entered into free trade agreements (FTAs) with the Republic of Korea and Japan, and concluded an FTA with China, in 2014, adding to existing FTAs with Chile, Malaysia, New Zealand, Singapore, Thailand, and the US, and a regional FTA with ASEAN and New Zealand. Australia continues to negotiate bilateral agreements with India and Indonesia, as well as larger agreements with its Pacific neighbors and the Gulf Cooperation Council countries, and an Asia-wide Regional Comprehensive Economic Partnership that includes the ten ASEAN countries and China, Japan, Korea, New Zealand and India. Australia is also working on the Trans-Pacific Partnership Agreement with Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the US, and Vietnam.
|
Source
: CIA |
ANZCHEM PTY LTD
ACN: 103 260 215
ABN: 27 103 260
215
|
Established |
2002 |
|
|
Incorporated |
2002 |
|
|
Line of Business |
Distribution of pharmaceutical, animal health and food ingredients |
|
|
Status |
Trading |
|
|
Adverse Listings |
|
|
|
Anzchem Pty Ltd |
|
||
|
|
As at 31 August 2014 |
As at 31 August 2013 |
Change (%) |
|
Revenue |
$14,664,050.00 |
$16,856,206.00 |
-13.01% |
|
Profit b/tax |
$556,668.00 |
$1,842,232.00 |
-69.78% |
|
Profit a/tax |
$394,093.00 |
$1,290,709.00 |
-69.47% |
|
Net Profit Margin |
2.69% |
7.66% |
-4.97% |
During fiscal 2014, the subject recorded Net Cashflows from operating
activities totalling $1,811,493.
As at 31 August 2014 the subject recorded Working Capital of $7,851,743 and
a current ratio of 3.61 to 1 indicating strong liquidity levels.
Net Assets
totalled $8,154,257 as at 31 August 2014. Nil intangibles were recorded at this
time.
Company Type Australian
Proprietary Company
Status Registered
Incorporation
Date 30 December 2002
Incorporation
State VIC
Registered
Office 'BUILDING A'
LEVEL 1, 11
TALAVERA ROAD NORTH RYDE
NSW, 2113
Current
Directors Total: 4
Director Name
CULLEN, ANDREW GERARD
Appointment Date
18 AUG 2014
Date of Birth 17
OCT 1970
Address 43
DARNLEY ST GORDON NSW 2072
Director Name
FERNANDO, CHRYSANTHUS
Appointment Date
18 AUG 2014
Date of Birth 13
MAY 1952
Address 88 HIGHS
RD WEST PENNANT HILLS, NSW 2125
Director Name
SINGH, MANJIT
Appointment Date
30 October 2007
Date of Birth 27
March 1955
Place of Birth
MOMBASSA KENYA
Gender MALE
Resident
Overseas N
Address 7A
BERNARD PL,
CHERRYBROOK NSW
2126
Document Number
1F0143681
Director Name
KAYAL, SHUVASIS RANA
Appointment Date
21 January 2003
Date of Birth 07
February 1961
Place of Birth
CALCUTTA INDIA
Gender UNKNOWN
Resident
Overseas Y
Address -
Document Number
018863772
Current
Secretaries Total: 1
Secretary Name
CULLEN, ANDREW GERARD
FRANK
Appointment Date
26 February 2013
Date of Birth 17
October 1970
Place of Birth
LONDON UNITED KINGDOM
Address 43
DARNLEY STREET GORDON
NSW, 2072
Document Number
1F0467463
Company
Shares Total: 50000 Amount: $50,000
Class ORDINARY
SHARES [ORD]
Number of Shares
Issued 50000
Paid Capital
$50,000.00
Total Amount Due
and Payable $0.00
Document Number
10326021M
Current
Shareholders
Shareholder Name
SPI PHARMA INC
Address 321
CHERRY LANE NEW CASTLE
DE 19720 UNITED
STATES
Class ORD
Number Held
50000
Beneficially
Held Y
Fully Paid Y
Jointly Held N
Document Number 10326021M
Effective 30 January 2012 the Personal Property Securities Register
(PPSR) was introduced to give the
different Commonwealth, State and Territory laws and registers regarding
security interests in personal property under one national system.
As a result of PPS Reform a number of existing Commonwealth, State and
Territory personal property security registers will close. Interests registered
on existing security interest registers will be migrated to the national PPS
Register. Subsequently Registered Charges are no longer lodged with the
Australian Securities and Investments Commission (ASIC).
Please contact us should you require a search of the PPSR.
TRADING ADDRESS 1 Braidwood Street
, Enfield
New South Wales,
2136
AUSTRALIA
POSTAL ADDRESS 5264, Chullora ,
New
South Wales , 2190
TELEPHONE (612) 9475 2200
FACSIMILE (612)
9475 2211
EMAIL info@anzchem.com.au
WEBSITE www.anzchem.com.au
HOLDING ENTITY SPI
PHARMA INC –USA
ULTIMATE HOLDING
ENTITY WITTINGTON
INVESTMENTS LTD - UK
BANK Not
determined
EMPLOYEES Not determined
The subject was incorporated in New South Wales on 30 December 2002
before adopting the current style on 22 January 2003.
The subject was formed in late 2002 as the regional office for SPI
Pharma Inc.
The subject operates as a supplier of pharmaceuticals, veterinarian and
food ingredient products represent a number of renowned international
manufacturers
Activities are conducted from premises located at the above listed
trading address.
A search of of on 19 July 2015 failed to trace any litigation listed
against the subject at that date.
During the current investigation contact with the subject’s financial
controller was unable to be established. Despite messages left, no reply has
been received.
From the subjects most recently lodged financial statements, it is noted
that for the financial year ended 31 August 2014 the subject recorded revenue
of $14,664,050, which resulted in an operating profit before tax of $556,668
and an operating profit after tax of $394,093 representing a Net Profit Margin
of 2.7%.
Below is a summary of the subject’s income results for the past two
financial years.
|
Anzchem Pty Ltd |
|
||
|
|
As at 31 August 2014 |
As at 31 August 2013 |
Change (%) |
|
Revenue |
$14,664,050.00 |
$16,856,206.00 |
-13.01% |
|
Profit b/tax |
$556,668.00 |
$1,842,232.00 |
-69.78% |
|
Profit a/tax |
$394,093.00 |
$1,290,709.00 |
-69.47% |
|
Net Profit Margin |
2.69% |
7.66% |
-4.97% |
During fiscal 2014, the subject recorded Net Cashflows from operating
activities totalling $1,811,493.
As at 31 August 2014 the subject recorded total current assets of
$10,867,712. They included cash of $5,269,714, receivables of $2,994,219 and
inventories of $2,603,779.
Current liabilities at the same date totalled $3,015,989 and included
payables of $2,728,015.
As at 31 August 2014 the subject recorded Working Capital of $7,851,743
and a current ratio of 3.61 to 1 indicating strong liquidity levels.
Net Assets totalled $8,154,257 as at 31 August 2014. At this date, the
subject further recorded a Debt to Equity ratio of 0.37 to 1 showing low levels
of gearing.
|
Anzchem Pty Ltd |
|
||
|
|
As at 31 August 2014 |
As at 31 August 2013 |
Change (%) |
|
Revenue |
$14,664,050.00 |
$16,856,206.00 |
-13.01% |
|
Profit b/tax |
$556,668.00 |
$1,842,232.00 |
-69.78% |
|
Profit a/tax |
$394,093.00 |
$1,290,709.00 |
-69.47% |
|
Net Profit Margin |
2.69% |
7.66% |
-4.97% |
|
Current Assets |
$10,867,712.00 |
$10,850,764.00 |
0.16% |
|
Non Current Assets |
$302,514.00 |
$253,403.00 |
19.38% |
|
Total Assets |
$11,170,226.00 |
$11,104,167.00 |
0.59% |
|
Current Liabilities |
$3,015,969.00 |
$3,224,242.00 |
-6.46% |
|
Non Current Liabilities |
|
$10,461.00 |
-100.00% |
|
Total Liabilities |
$3,015,969.00 |
$3,234,703.00 |
-6.76% |
|
Net Assets |
$8,154,257.00 |
$7,869,464.00 |
3.62% |
|
Working Capital |
$7,851,743.00 |
$7,626,522.00 |
2.95% |
|
Current Ratio |
3.60 |
3.37 |
7.07% |
|
Debt to Equity |
0.37 |
0.41 |
-10.02% |

Trade payment from further sources in the past 4 months have traced the
following data.
Total Owing: $476
Total Past Due:
$320
within terms: $156
1 – 30 days past due: $280
31 – 60 days past due: $40
61 – 90 days past due: $0
91+ days: $0
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.65.23 |
|
|
1 |
Rs.102.21 |
|
Euro |
1 |
Rs.72.57 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.